The Helmerich Maneuver

Recs

9

Yesterday, I noted how Dawson Geophysical's (Nasdaq: DWSN) ability to deliver efficiency to its customers helps the seismic firm pump up prices and profits. In a much more challenging market, Helmerich & Payne (NYSE: HP) is bringing home the bacon in a similar way.

H&P has avoided falling victim to the domestic oversupply of commoditized rigs, thanks to a little secret weapon called the FlexRig. This is an in-house rig design that excels at performing directional drilling and other demanding applications. Because the FlexRig reduces the number of days required to drill a well, it is still economical for operators to employ H&P's rigs at a higher dayrate than what they would pay for an old mechanical rig. Everybody wins.

In its fourth fiscal quarter, H&P pretty much stomped its competitors in every way. U.S. land rig utilization came in at 95%, whereas Patterson-UTI (Nasdaq: PTEN) fielded only 243 of its 350 or so rigs. Dayrates rose sequentially to more than $23,000, or 17% higher than what gusher-free Grey Wolf (AMEX: GW) charged for daywork. Most triumphant, however, was H&P's daily rig margin, which in percentage terms slightly edged out even Unit Corp's (NYSE: UNT) uniquely strong result.

With 83 FlexRig commitments for three-year terms or longer, H&P is sitting pretty, no matter what wackiness befalls the lower 48 drillers in the near term. If you're seeking more leverage to the hot international land drilling market, plied by the likes of Nabors Industries (NYSE: NBR) and Parker Drilling (NYSE: PKD), don't forget that H&P also has an international segment. Between its domestic dominance and its foreign foothold, Helmerich & Payne is perplexingly cheap, even after yesterday's post-results pop.

“Make Big Money With Options” Motley Fool CFO Ollen Douglass recently made over $100,000 buying options on 7 well known stocks. Now we’re committed to turning his small fortune into a massive one! And we want you to join us! Enter your email address to hear more:

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 540338, ~/Articles/ArticleHandler.aspx, 12/1/2009 11:05:51 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
The Public Health-Care Plan's Problem

Related Tickers

12/1/2009 10:48 AM
UNT $38.29 Up +0.68 +1.81%
Unit Corp CAPS Rating: *****
PKD $5.01 Up +0.01 +0.20%
Parker Drilling Co… CAPS Rating: ****
DWSN $22.14 Up +0.50 +2.31%
Dawson Geophysical… CAPS Rating: *****
PTEN $15.57 Up +0.18 +1.17%
Patterson-UTI Ener… CAPS Rating: ***
NBR $20.94 Up +0.29 +1.40%
Nabors Industries… CAPS Rating: *****
GW $3.41 Down +0.00 +0.00%
Grey Wolf, Inc. CAPS Rating: *****
HP $38.06 Up +0.51 +1.36%
Helmerich & Payne,… CAPS Rating: ****

Community: Investing Wiki

Term Of The Hour

PDUFA: The Prescription Drug User Fee Act (PDUFA) is a law enacted by Congress that gives powers to the FDA.

Want to learn more or edit this definition?
Click here to read more!